---

PHARMACEUTICAL RESEARCH

There are 64 new drugs in development to treat mental illnesses. This

represents an increase of 18 medicines since 1994, according to the 1996

reports from the Pharmaceutical Research and Manufacturers of America.

 

The industry estimates that in 1996 its companies will invest about $3

billion on drug research related to the central nervous system. This is

second only to cancer-related drugs in research investment by pharmaceutical

companies.

 

New drug treatments in development include: 17 for schizophrenia and

psychosis, 13 for depression and manic-depression, and 12 new drugs for

anxiety disorders.

---